In a groundbreaking development, Vivos Therapeutics has achieved a significant milestone with the issuance of a FDA 510(k) clearance for its CARE oral medical devices designed to treat severe Obstructive Sleep Apnea (OSA). This achievement marks a paradigm shift in the field of sleep medicine, as Vivos Therapeutics has successfully paved the way for a non-invasive and highly effective treatment option for individuals suffering from this debilitating condition.Obstructive Sleep Apnea, a chronic disorder characterized by repeated episodes of breathing cessation during sleep, affects millions worldwide and has long posed a challenge in terms of treatment efficacy. However, Vivos Therapeutics' proprietary CARE o...

Revitalizing Growth: Vivos Therapeutics' Distribution Deal and the Battle Against Revenue Decline

Vivos Therapeutics, a leading provider of oral appliances for treating sleep apnea, has recently signed an exclusive nationwide distribution agreement with Lincare. This strategic partnership aims to expand the reach of Vivos' innovative oral appliances, ensuring that more individuals suffering from sleep apnea can receive effective treatment. Additionally, the company reported a revenue decrease in the second quarter of 2023 compared to its competitors. Let's examine the significance of these developments and their impact on Vivos Therapeutics.
Nationwide Distribution Agreement with Lincare:
Vivos Therapeutics has reached a significant milestone with the signing of an exclusive nationwide ...

VVOS's Stock Performance relative to its Competitors

Who are Vivos Therapeutics Inc 's Competitors?

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com